PUT - SPRINTER OPEN END - IDEXX LABORATORIES Stock

Certificat

DE000VM59MV3

Market Closed - Boerse Frankfurt Warrants 02:03:18 2024-06-14 pm EDT
0.85 EUR 0.00% Intraday chart for PUT - SPRINTER OPEN END - IDEXX LABORATORIES
Current month-8.60%
1 month+18.06%
Date Price Change
24-06-14 0.85 0.00%
24-06-13 0.85 +10.39%
24-06-12 0.77 -6.10%
24-06-11 0.82 +3.80%
24-06-10 0.79 -12.22%

Real-time Boerse Frankfurt Warrants

Last update June 14, 2024 at 02:03 pm EDT

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying IDEXX LABORATORIES, INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VM59MV
ISINDE000VM59MV3
Date issued 2023-11-30
Strike 593.5 $
Maturity Unlimited
Parity 100 : 1
Emission price 1.16
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.14
Lowest since issue 0.12

Company Profile

IDEXX Laboratories, Inc. is a world leader in the design, development and marketing of diagnostic test instruments for animal health monitoring and analysis of dairy products and water. Net sales break down by area of application as follows: - veterinary diagnoses for pets (91.6%); - water quality analysis (4.6%); - veterinary diagnoses for livestock and poultry (3.3%): solutions that help detect infectious diseases in ruminants, pigs, poultry and horses. The group also offers test solutions for dairy products; - other (0.5%). Net sales by source of income break down between product sales (57.1%) and services (42.9%). Net sales are distributed geographically as follows: the United States (65.3%), Canada (4.1%), Americas (2.3%), Germany (4.1%), the United Kingdom (3.3%), France (2.7%), Italy (1.5%), Spain (1.4%), Switzerland (0.9%), the Netherlands (0.8%), Europe/Middle East/Africa (4.8%), Australia (2.6%), Japan (2.1%), China (1.2%) and Asia/Pacific (2.9%).
Sector
-
More about the company

Ratings for IDEXX Laboratories, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: IDEXX Laboratories, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
504 USD
Average target price
565.1 USD
Spread / Average Target
+12.11%
Consensus